COSMOS Pharmaceutical Corporation
CSMYF · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $42 | $24 | $33 | $33 |
| Dep. & Amort. | $22 | $20 | $17 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$9 | $7 | $10 | -$1 |
| Other Non-Cash | -$4 | $3 | -$6 | -$15 |
| Operating Cash Flow | $52 | $55 | $54 | $32 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$53 | -$56 | -$47 | -$43 |
| Net Acquisitions | $0 | $0 | $0 | $2 |
| Inv. Purchases | $0 | $0 | -$1 | -$1 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$2 | -$2 | -$2 | -$1 |
| Investing Cash Flow | -$55 | -$57 | -$49 | -$44 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15 | $15 | $8 | -$1 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$0 | $0 | $0 | -$0 |
| Dividends Paid | -$5 | -$5 | -$3 | -$3 |
| Other Fin. Act. | -$2 | -$2 | -$2 | -$2 |
| Financing Cash Flow | $8 | $9 | $3 | -$6 |
| Forex Effect | $0 | $0 | $0 | -$0 |
| Net Chg. in Cash | $5 | $6 | $9 | -$18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52 | $46 | $37 | $55 |
| End Cash | $57 | $52 | $46 | $37 |
| Free Cash Flow | -$1 | -$1 | $8 | -$11 |